News Drug Formulary Safety Net Resources
Drug Formulary Categories and Charges Search HA Drug Formulary Self-financed Drugs Available for Purchase by Patients at HA Pharmacy How we evaluate new drugs Governance Drug Management Committee Drug Advisory Committee Drug Formulary Committee Drug & Therapeutics Committee Drug Selection Committee Expert Panel Medication Safety Committee Samaritan Fund Community Care Fund Drug Education HA Drug Formulary Management Manual Frequently Asked Questions Useful Links
HA Drug Formulary
Version 22.2 – with effect from 31 October 2026
  1. The drugs may either be listed as generic or proprietary names, where appropriate. Brand names listed serve as reference only, they do not necessarily indicate the availability of that particular brand.
  2. Some drugs may appear in more than one category due to different formulations and/or indications.
  3. The "Special" drugs will be prescribed as clinically indicated based on the specified indications.
  4. Based on operational logistics and needs, individual cluster/hospital may only stock part of the drugs listed on the HA Drug Formulary.
Drug classes
Result of:
Malignant disease & Immunosuppression
General Drugs Special Drugs Self-financed Items
with Safety Net		 Self-financed Items
without Safety Net
Malignant disease & Immunosuppression
General Drugs Special Drugs Self-financed Items
with Safety Net		 Self-financed Items
without Safety Net
CYTOTOXIC DRUGS
ACTINOMYCIN D ARSENIC TRIOXIDE ABEMACICLIB ACALABRUTINIB
ASPARAGINASE AZACITIDINE (VIDAZA) ACALABRUTINIB ALPELISIB
BLEOMYCIN BENDAMUSTINE AFATINIB AMIVANTAMAB
CALCIUM FOLINATE BLINATUMOMAB ALECTINIB ASCIMINIB
CAPECITABINE BUSULPHAN APALUTAMIDE ATEZOLIZUMAB
CARBOPLATIN CETUXIMAB ASCIMINIB BEVACIZUMAB
CARMUSTINE CLADRIBINE ATEZOLIZUMAB BORTEZOMIB
CHLORAMBUCIL CLOFARABINE AVELUMAB CABOZANTINIB (CABOMETYX)
CISPLATIN CRISANTASPASE (ASPARAGINASE ERW) AXITINIB CAPIVASERTIB
CYCLOPHOSPHAMIDE DASATINIB AZACITIDINE (ONUREG) CAPMATINIB
CYTARABINE ERIBULIN AZACITIDINE (VIDAZA) CARFILZOMIB
DACARBAZINE ERLOTINIB BELZUTIFAN CETUXIMAB
DAUNORUBICIN EVEROLIMUS (AFINITOR) (OR EQUIV) BENDAMUSTINE DABRAFENIB
DOCETAXEL FLUDARABINE BEVACIZUMAB DACOMITINIB
DOXORUBICIN FRUQUINTINIB BORTEZOMIB DOSTARLIMAB
EPIRUBICIN GEFITINIB BRENTUXIMAB VEDOTIN DOXORUBICIN (LIPOSOMAL)
ETOPOSIDE IFOSFAMIDE BRIGATINIB DURVALUMAB
FLUOROURACIL IMATINIB CABOZANTINIB (CABOMETYX) ENFORTUMAB VEDOTIN
GEMCITABINE MITOXANTRONE CARFILZOMIB EPCORITAMAB
HYDROXYUREA PEGASPARAGINASE CETUXIMAB ESTRAMUSTINE
IDARUBICIN SORAFENIB CRIZOTINIB EVEROLIMUS (AFINITOR) (OR EQUIV)
IRINOTECAN TEMOZOLOMIDE DABRAFENIB LENVATINIB
LOMUSTINE THIOTEPA DARATUMUMAB NIRAPARIB (TOSYLATE)
MELPHALAN TOPOTECAN DOSTARLIMAB OBINUTUZUMAB
MERCAPTOPURINE TRASTUZUMAB DOXORUBICIN (LIPOSOMAL) OLAPARIB
MESNA TS-1 (OR EQUIV) DURVALUMAB PACLITAXEL (ALBUMIN)
METHOTREXATE VINORELBINE ELRANATAMAB PAZOPANIB
MITOMYCIN ENCORAFENIB PEMBROLIZUMAB
MITOTANE ENFORTUMAB VEDOTIN PERTUZUMAB + TRASTUZUMAB
OXALIPLATIN EVEROLIMUS (AFINITOR) (OR EQUIV) PRALSETINIB
PACLITAXEL GEMTUZUMAB REGORAFENIB
PEMETREXED GILTERITINIB SELPERCATINIB
PROCARBAZINE GLOFITAMAB SUNITINIB
THIOGUANINE IBRUTINIB TISLELIZUMAB
TRETINOIN INOTUZUMAB OZOGAMICIN TRAMETINIB
VINBLASTINE IPILIMUMAB TRASTUZUMAB DERUXTECAN
VINCRISTINE ISATUXIMAB TRASTUZUMAB EMTANSINE
IXAZOMIB TRIFLURIDINE + TIPIRACIL
LAPATINIB VENETOCLAX
LENVATINIB ZOLBETUXIMAB
LORLATINIB ZONGERTINIB
MIDOSTAURIN
NERATINIB
NILOTINIB
NIRAPARIB (TOSYLATE)
NIVOLUMAB
OBINUTUZUMAB
OLAPARIB
OSIMERTINIB
PACLITAXEL (ALBUMIN)
PALBOCICLIB
PANITUMUMAB
PAZOPANIB
PEMBROLIZUMAB
PERTUZUMAB
PERTUZUMAB + TRASTUZUMAB
POLATUZUMAB VEDOTIN
PONATINIB
QUIZARTINIB DIHYDROCHLORIDE
RIBOCICLIB
RUXOLITINIB
SACITUZUMAB GOVITECAN
SELINEXOR
SELUMETINIB
SUNITINIB
TEMOZOLOMIDE
TEPOTINIB
TORIPALIMAB
TRAMETINIB
TRASTUZUMAB
TRASTUZUMAB DERUXTECAN
TRASTUZUMAB EMTANSINE
TREMELIMUMAB
VENETOCLAX
ZANUBRUTINIB
DRUGS AFFECTING THE IMMUNE RESPONSE
AZATHIOPRINE ALEMTUZUMAB (LEMTRADA) BELUMOSUDIL LENALIDOMIDE
BCG ANTITHYMOCYTE IMMUNOGLOBULIN BENRALIZUMAB RITUXIMAB
THALIDOMIDE BASILIXIMAB BUDESONIDE
CYCLOSPORIN A CANAKINUMAB
CYCLOSPORIN A (NEORAL) CLADRIBINE (MAVENCLAD)
CYCLOSPORIN A (TEVA) INTERFERON GAMMA
DIMETHYL FUMARATE LENALIDOMIDE
EVEROLIMUS (CERTICAN) (OR EQUIV) MEPOLIZUMAB
FINGOLIMOD MOMELOTINIB
INTERFERON BETA POMALIDOMIDE
MYCOPHENOLATE RITUXIMAB
NATALIZUMAB SILTUXIMAB
OFATUMUMAB SIPONIMOD
PEGINTERFERON ALFA
RITUXIMAB
SIROLIMUS
TACROLIMUS
TERIFLUNOMIDE
SEX HORMONES AND HORMONE ANTAGONISTS IN MALIGNANT DISEASE
LETROZOLE ANASTROZOLE ABIRATERONE ABIRATERONE
MEDROXYPROGESTERONE ACETATE BICALUTAMIDE ENZALUTAMIDE DAROLUTAMIDE
MEGESTROL BUSERELIN FULVESTRANT ELACESTRANT
OCTREOTIDE CYPROTERONE ENZALUTAMIDE
SOMATOSTATIN DEGARELIX FULVESTRANT
TAMOXIFEN EXEMESTANE
FLUTAMIDE
GOSERELIN
LANREOTIDE
LEUPRORELIN
OCTREOTIDE
PASIREOTIDE
TRIPTORELIN
RADIOPHARMACEUTICALS
LUTETIUM OXODOTREOTIDE
LUTETIUM VIPIVOTIDE TETRAXETAN